This may be due to tumor heterogeneity, specific neutrophil gene phenotypes, and reduced production of key components of antitumor immunity, including IL12, BATF3-dependent DCs, IFNɣ, and the CXCR3 chemokine receptor. Here, IFNA1 is linked to neoplasm.